Pharma news
Americas
Pfizer’s associate general counsel, Justin McCarthy, has sent a letter to India’s ambassador to the US, Subrahmanyam Jaishankar, urging the Indian government to “shift from using destructive IP policy as an access strategy,” according to reports. 25 April 2014
Pharma
Novartis and GSK have agreed to create a consumer healthcare business in a joint venture that involves the exchange of assets worth billions of dollars. 23 April 2014
Americas
A group of generic drug manufacturers has asked the US Supreme Court to allow a ruling that grants them permission to market a version of Teva’s multiple sclerosis drug Copaxone (glatiramer acetate). 15 April 2014
Americas
Law firm Mintz Levin Cohn Ferris Glovsky and Popeo PC has added three partners to its IP team. 11 April 2014
Americas
Schiff Hardin LLP has expanded its IP group with the hiring of Imron Aly as a partner. 2 April 2014
Asia-Pacific
Gilead Sciences has received another challenge to its application to patent its new hepatitis C drug Sovaldi (sofosbuvir) in India. 26 March 2014
Americas
Horizon Pharma is set to acquire Dublin-based Vidara Therapeutics in a merger worth about $660 million, the companies announced on March 19. 20 March 2014
Americas
Pfizer has filed patent infringement suits against India-based Torrent Pharmaceuticals in an attempt to stop it selling a generic version of erectile dysfunction drug Viagra (sildenafil citrate). 18 March 2014
Pharma
While the political will exists for the introduction of the Unified Patent Court next year, much more still needs to be done, according to Adam Cooke, a partner in DLA Piper's IP and technology group. 5 March 2014
Pharma
A key concern for lawyers and in-house counsels practising in the pharmaceutical industry is the disclosure of clinical data, according to the co-chairs of DLA Piper's Global Life Sciences sector, Bonella Ramsay and John Dougherty. 4 March 2014